{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:53:03Z","timestamp":1782237183560,"version":"3.54.5"},"reference-count":91,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["headachejournal.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Headache"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To review the published findings relevant to migraine and driving performance, with an intent to encourage discussion on research which may broaden understanding in this area and help educate healthcare providers and their patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Motor vehicle crashes result in more than 35,000 deaths and more than 2\u00a0million injuries annually in the United States. Migraine is one of the most prevalent diseases in the world, and many symptoms associated with migraine attacks have the potential to negatively influence driving ability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed the published findings related to migraine and driving performance. Study findings relevant to symptoms of migraine and their potential effect on driving were also reviewed. This required a more expansive exploration of the literature beyond migraine, for example, review of the literature relating to the effect of pain, sleepiness, visual disturbances, or vertigo on driving. Finally, the potential effects of treatment for migraine on driving were reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Literature on the effect of migraine on driving performance is sparse and, in general published studies on the topic have a number of limitations. Based on review of the literature pertaining to other disorders, it seems feasible that some symptoms occurring as part of the migraine attack could impact driving performance, although formal study in this area is lacking. Many of the approved treatments for migraine have the potential to impact driving, yet this has not been specifically studied, and the extent to which these risks are communicated to patients is not clear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The impact of migraine on driving performance has been largely neglected, with few studies specifically designed to address the topic, and relevant studies were generally small with limited control of confounders. This area requires more focus, given a potential for impact on road safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/head.13716","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T02:35:15Z","timestamp":1575340515000},"page":"178-189","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings"],"prefix":"10.1111","volume":"60","author":[{"given":"Stewart J.","family":"Tepper","sequence":"first","affiliation":[{"name":"Geisel School of Medicine at Dartmouth Hanover NH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Silberstein","sequence":"additional","affiliation":[{"name":"Jefferson Headache Center Thomas Jefferson University Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah L.","family":"Rosen","sequence":"additional","affiliation":[{"name":"Northwell Health Physician Partners Neuroscience Institute Great Neck NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[{"name":"Montefiore Headache Center Albert Einstein School of Medicine The Bronx NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen B.","family":"Dennehy","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Indianapolis IN USA"},{"name":"Department of Psychological Sciences Purdue University West Lafayette IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherie A.","family":"Dowsett","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Doty","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2015.06.011"},{"key":"e_1_2_7_3_1","first-page":"26","volume-title":"Winnable Battles Final Report","author":"Center for Disease Control and Prevention","year":"2016"},{"key":"e_1_2_7_4_1","first-page":"51","article-title":"Deaths: Final data for 2017","volume":"68","author":"Kochanek KD","year":"2019","journal-title":"Natl Vital Stat Rep"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2011.11.015"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005210"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-015-0007-3"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsy023"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2011.01.002"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmrj.2011.10.008"},{"key":"e_1_2_7_11_1","volume-title":"Driving with Dementia: Understanding the Safety Risks","author":"American Academy of Neurology","year":"2010"},{"key":"e_1_2_7_12_1","volume-title":"Dementia and Driving","author":"Alzheimer's Association","year":"2010"},{"key":"e_1_2_7_13_1","volume-title":"Drugged Driving Expert Panel Report: A Consensus Protocol for Assessing the Potential of Drugs to Impair Driving","author":"Kay GG","year":"2011"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2016.08.001"},{"key":"e_1_2_7_15_1","volume-title":"Drug Impaired Driving","author":"National Highway Traffic Safety Administration"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000252808.97649.21"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31678-6"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30478-1"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000052998.58526.A9"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002789"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.3233\/VES-2012-0453"},{"key":"e_1_2_7_22_1","volume-title":"The International Classification of Headache Disorders (beta version)","author":"Headache Classification Committee of the International Headache Society","year":"2013"},{"key":"e_1_2_7_23_1","volume-title":"Evaluating Drug Effects on the Ability to Operate a Motor Vehicle \u2013 Guidance for Industry","author":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)","year":"2017"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100047697"},{"key":"e_1_2_7_25_1","first-page":"1","article-title":"Perception of the impact of certain health conditions on driving performance","volume":"2","author":"Alonso F","year":"2017","journal-title":"Public Health Int"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-4575(97)00018-3"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/15389588.2012.654411"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/09638288.2010.511687"},{"key":"e_1_2_7_29_1","first-page":"33","article-title":"Migraine associated with road traffic accidents in United Arab Emirates","volume":"6","author":"Bener A","year":"2001","journal-title":"Neurosciences"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199512000-00007"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-015-0566-9"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.12.019"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414553823"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417728250"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-017-2814-z"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.111006377.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0933-4"},{"key":"e_1_2_7_38_1","first-page":"4913","article-title":"Cognitive impairment and quality of life in patients with migraine\u2010associated vertigo","volume":"20","author":"Wang N","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1037\/pas0000432"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12168"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2007.01303.x"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/oem.56.5.289"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7346.1125"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.23.1908"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleh.2016.04.003"},{"key":"e_1_2_7_46_1","volume-title":"Drowsy Driving","author":"National Highway Traffic and Safety Administration","year":"2019"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsr.2003.09.009"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00557"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-0149-2"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13330"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014520882"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2016.08.001"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-012-0833-8"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61566-9"},{"key":"e_1_2_7_55_1","volume-title":"Allergy Meds Could Affect Your Driving","author":"US Food and Drug Administration","year":"2014"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12499"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182535d20"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02748.x"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2004.00694.x"},{"key":"e_1_2_7_60_1","unstructured":"AXERT\u00ae (almotriptan malate) tablets [package insert].Titusville NJ:Janssen Pharmaceuticals Inc.;2009. Available athttp:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/AXERT-pi.pdf. Accessed August 16 2019."},{"key":"e_1_2_7_61_1","unstructured":"FROVA\u00ae (frovatriptan succinate) tablets [package insert].Malvern PA:Endo Pharmaceuticals Inc.;2013. Available athttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021006s019lbl.pdf. Accessed August 16 2019."},{"key":"e_1_2_7_62_1","unstructured":"Imitrex (sumatriptan succinate) tablets [package insert].Research Triangle Park NC:GlaxoSmithKline;2017. Available athttps:\/\/www.gsksource.com\/pharma\/content\/dam\/GlaxoSmithKline\/US\/en\/Prescribing_Information\/Imitrex_Tablets\/pdf\/IMITREX-TABLETS-PI-PIL.PDF. Accessed August 16 2019."},{"key":"e_1_2_7_63_1","unstructured":"MAXALT (rizatriptan benzoate) tablets [package insert].Whitehouse Station NJ:Merck & Company Inc;2011. Available athttps:\/\/www.merck.com\/product\/usa\/pi_circulars\/m\/maxalt\/maxalt_ppi.pdf. Accessed August 16 2019."},{"key":"e_1_2_7_64_1","unstructured":"RELPAX\u00ae (eletriptan hydrobromide) tablets [package insert].New York NY:Pfizer;2013. Available athttp:\/\/labeling.pfizer.com\/ShowLabeling.aspx?format=PDF&xml:id=621. Accessed August 16 2019."},{"key":"e_1_2_7_65_1","unstructured":"AMERGE\u00ae (naratriptan hydrochloride) tablets [package insert].Research Triangle Park NC:GlaxoSmithKline;2016. Available athttps:\/\/www.gsksource.com\/pharma\/content\/dam\/GlaxoSmithKline\/US\/en\/Prescribing_Information\/Amerge\/pdf\/AMERGE-PI-PIL.PDF. Accessed August 16 2019."},{"key":"e_1_2_7_66_1","unstructured":"ZOMIG (zolmitriptan) tablets [package insert].Bridgewater NH:Astra Zeneca distributed by Amneal Specialty a division of Amneal Pharmaceuticals LLC;2019. Available athttps:\/\/www.azpicentral.com\/zomig\/zomig.pdf#page=1. Accessed August 16 2019."},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1001\/2013.jamainternmed.733"},{"key":"e_1_2_7_68_1","unstructured":"VICODIN (hydrocodone bitartrate and acetaminophen) tablet [package insert].North Chicago IL:AbbVie Inc.;2012. Available athttps:\/\/www.rxabbvie.com\/pdf\/vicodin_apap_300mg_hydrocodone_5mg-7_5mg-10mg_PI.pdf. Accessed August 16 2019."},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/1556-4029.12143"},{"key":"e_1_2_7_70_1","unstructured":"Fiorinal\u00ae (Butalbital Aspirin and Caffeine Capsules USP) [package insert].Madison NJ:Allergan;2018. Available athttps:\/\/www.allergan.com\/assets\/pdf\/fiorinal-pi. Accessed August 16 2019."},{"key":"e_1_2_7_71_1","unstructured":"Inderal\u00ae (propranolol hydrochloride) tablets [package insert].Philadelphia PA:Wyeth Pharmaceuticals Inc;2017. Available athttp:\/\/labeling.pfizer.com\/ShowLabeling.aspx?xml:id=9895. Accessed August 16 2019."},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/13.3.259"},{"key":"e_1_2_7_73_1","unstructured":"Amitriptyline hydrochloride tablet [package insert].Morgantown WV:Mylan Pharmaceuticals Inc;2016. Available athttps:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setxml:id=61d2da8d-b435-4ada-a013-401786f7cace&type=display. Accessed August 16 2019."},{"key":"e_1_2_7_74_1","unstructured":"TOPAMAX\u00ae (topiramate) tablets [package insert].Titusville NJ:Janssen Pharmaceuticals Inc.;2009. Available athttp:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/TOPAMAX-pi.pdf. Accessed August 16 2019."},{"key":"e_1_2_7_75_1","unstructured":"Depakote (divalproex sodium) delayed\u2010release tablets [package insert].North Chicago IL:AbbVie Inc.;2019. Available athttps:\/\/www.rxabbvie.com\/pdf\/depakote.pdf. Accessed August 16 2019."},{"key":"e_1_2_7_76_1","unstructured":"NEURONTIN (gabapentin) capsules [package insert].New York NY:Pfizer;2017. Available athttp:\/\/labeling.pfizer.com\/ShowLabeling.aspx?xml:id=630. Accessed August 16 2019."},{"key":"e_1_2_7_77_1","unstructured":"BOTOX (onabotulinumtoxinA) for injection [package insert].Irvine CA:Allergan Inc;2011. Available athttps:\/\/www.allergan.com\/assets\/pdf\/botox_pi.pdf. Accessed August 16 2019."},{"key":"e_1_2_7_78_1","unstructured":"AIMOVIG\u00ae (erenumab) injection [package insert].Thousand Oaks CA:Amgen Inc;2019. Available athttps:\/\/www.pi.amgen.com\/~\/media\/amgen\/repositorysites\/pi-amgen-com\/aimovig\/aimovig_pi_hcp_english.ashx. Accessed August 19 2019."},{"key":"e_1_2_7_79_1","unstructured":"AJOVY\u00ae (fremanezumab) injection [package insert].North Wales PA:Teva Pharmaceuticals USA Inc;2019. Available athttps:\/\/www.ajovyhcp.com\/globalassets\/ajovy\/ajovy-pi.pdf. Accessed August 19 2019."},{"key":"e_1_2_7_80_1","unstructured":"EMGALITY (galcanezumab) injection [package insert].Indianapolis IN:Eli Lilly and Company;2019. Available athttps:\/\/pi.lilly.com\/us\/emgality-uspi.pdf. Accessed August 19 2019."},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2000.040008657.x"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12997"},{"issue":"1","key":"e_1_2_7_83_1","first-page":"22","article-title":"Effects of lasmiditan on driving performance: Results of 2 randomized, blinded, crossover simulated driving studies with placebo and active controls","volume":"59","author":"Pearlman E","year":"2019","journal-title":"Headache"},{"key":"e_1_2_7_84_1","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.5168"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2530"},{"key":"e_1_2_7_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4706-6"},{"key":"e_1_2_7_87_1","unstructured":"SPRAVATO\u2122 (esketamine) nasal spray CIII [package insert].Titusville NJ:Janssen Pharmaceuticals Inc.;2019. Available athttps:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/SPRAVATO-pi.pdf. Accessed August 16 2019."},{"key":"e_1_2_7_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.07.039"},{"key":"e_1_2_7_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2400-7"},{"key":"e_1_2_7_90_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102415580099"},{"key":"e_1_2_7_91_1","first-page":"26","article-title":"Impact of migraine and migraine treatment on patient's capacity to work and quality of life","volume":"2","author":"Chaushev N","year":"2009","journal-title":"J Clin Med"},{"key":"e_1_2_7_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32154-2"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.13716","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/head.13716","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.13716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:25:47Z","timestamp":1762075547000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/head.13716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1111\/head.13716"],"URL":"https:\/\/doi.org\/10.1111\/head.13716","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]},"assertion":[{"value":"2019-11-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}